Sacituzumab govitecan

Therapeutic Sacituzumab govitecan ADC from the original Trodelvy® commercial drug.

Showing the single result

Filter our product list:
API
Antigen / Target
Therapeutic Areas
Therapeutic Indications
Classes of molecule​s
Isotypes
Expiry Date
CoA
Filters Sort results
Reset Apply

Product
Batch

Antigen
Molecular Class
Drug Brand
Product Concentration
CoA
Quantity per vial
Storage Temperature
Expiry Date
Price from
Trop-2-directed ADC
Antibody-drug conjugate (ADC)
Trodelvy®
10 mg/mL
4 mg
-80°C
2025.08
308,00 
view product
Max: 8
Min: 1
Step: 1

Not looking for Sacituzumab govitecan?

Search our therapeutic molecules product database